Drug Profile
Diazoxide - Advancell/Neurotec
Alternative Names: ATH-0012; ATH-012; NT-KO-003Latest Information Update: 28 Feb 2023
Price :
$50
*
At a glance
- Originator Advancell; Neurotec Pharma
- Class Antihyperlipidaemics; Antihypertensives; Antihypoglycaemics; Benzothiadiazines; Obesity therapies; Peripheral vasodilators; Small molecules
- Mechanism of Action Immunomodulators; Potassium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Amyotrophic lateral sclerosis; CNS trauma; Multiple sclerosis
Most Recent Events
- 28 Feb 2023 Discontinued - Phase-II for Multiple sclerosis in Germany (PO)
- 28 Feb 2023 Discontinued - Phase-II for Multiple sclerosis in Spain (PO)
- 28 Feb 2023 Discontinued - Preclinical for Amyotrophic lateral sclerosis in Spain (unspecified route)